Health News (Reuters)

Oscar Health files to expand insurance coverage in several states

(Reuters) - Despite uncertainly over the future of U.S. healthcare that has prompted major health insurers to pull out of several markets, upstart provider Oscar Health on Wednesday said it has filed to sell health insurance to individuals through Obamacare exchanges in a total of six states in 2018.

Missouri attorney general sues opioid manufacturers

(Reuters) - Missouri's attorney general on Wednesday announced a lawsuit against three major drug manufacturers claiming they fraudulently misrepresented the risks posed by opioid painkillers now at the center of a national addiction epidemic.

Screen kids and teens for obesity, U.S. experts say

(Reuters Health) - Children and teens should be screened for obesity at doctors' offices starting at age 6 and advised to attend intensive weight management programs if needed, according to a U.S.-government backed panel.

Shire's long-acting ADHD drug wins U.S. approval

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Shire Plc's long-acting therapy for attention deficit hyperactivity disorder (ADHD), adding another treatment to its stock of drugs for the cognitive condition that affects millions of children.

Obamacare repeal imminent in Congress: Pence

WASHINGTON (Reuters) - Legislation to repeal major portions of Obamacare and replace them with a new healthcare system will be enacted into law within months, U.S. Vice President Mike Pence said on Tuesday.

Many Americans taking too much vitamin D

(Reuters Health) - Nearly one in five U.S. adults are taking supplemental vitamin D, and a growing number are taking excessively high doses linked to an increased risk of fractures, falls, kidney stones and certain cancers, a new study suggests.

Worldwide drug sale forecasts fall as pricing pressures mount

LONDON (Reuters) - Forecasts for global sales of pharmaceuticals have declined for the first time in a decade as continuing pressure on prices in the key U.S. market has caused analysts to moderate revenue expectations, according to a report on Tuesday.

Novartis eye drug works with fewer injections than rivals

ZURICH (Reuters) - A drug developed by Novartis to treat vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron to be effective, clinical trials showed on Tuesday.

Sharp rise in suicides by gun among American children is found

(Reuters) - American children died of self-inflicted gunshot wounds at a sharply higher rate in 2014 than seven years earlier, according to a study released on Monday, which said that the safe storage of firearms could make a big difference in preventing youth suicides.

Mindfulness-based childbirth classes may ease pain, depression

(Reuters Health) - When birthing classes include mindfulness-based education instead of focusing only on the biology of having a baby, women may have an easier time coping with labor pain and a lower risk of postpartum depression, a small experiment suggests.